Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech

Team Builds Microscopic Robot to Catch Diseases in Blood Samples

March 3, 2016 By Cathy Majtenyi, Brock University

The ultimate science fiction story: a robot smaller than the size of a pin head blasts its way into a patient’s bloodstream to battle a dreaded disease. 

Brock researcher Feng Li chuckles at the imagery and then gets excited. He points to a drawing of what looks like a sun with many squiggly rays sticking out. “This one cannot fix disease, but the idea is somehow similar.”

Li is referring to a “nanomachine” – a nano-sized robot – his research team created that has the potential to detect diseases in a blood sample within 30 minutes.

The three-dimensional, microscopic robot consists of a 20-nanometer particle made out of gold.

Short and long strands of deoxyribonucleic acid, or DNA, are attached to the gold particle. DNA is the main component of chromosomes and carries genetic information for all cells. But here DNA molecules are used as building blocks to construct and operate the nanomachine.

The Brock University research team exploring the use of nanobots to fight disease includes: Xiaolong Yang, left, Sean Mason, Trevor Ealaschuk, Ryan Alt, Feng Li, and Zechen Yu. (Credit: Brock University)

The long DNA strands contain the genetic sequences of whatever specific disease is being tested for, while the short DNA strands carry fluorescent signal reporters.

The robot is then dropped into serum extracted from human blood. If biomarkers for the specific disease are present in the serum, the machine turns on; if the sample is disease-free, the robot remains off.

Once turned on by disease biomarkers, the nanomachine automatically uses its long DNA strands to slice the short DNA strands, activating the fluorescent signals.

The serum sample will then glow.

Li and his team used their nanomachine to detect tuberculosis, a potentially fatal, infectious lung disease that causes havoc in some parts of the world.

“We tested our nanomachine using a fragment of tuberculosis DNA in the test-tube,” Li, Assistant Professor of chemistry, explains. “We mixed this DNA fragment into the human serum obtained from healthy donors to mimic a TB patient sample. We then added our specifically-designed nanomachine into this serum sample and measured the fluorescence generated from the nanomachine.”

“The nanomachine was able to successfully detect TB in the human serum sample,” says Li. The team described results in their recent paper, “Enzyme-Powered Three-Dimensional DNA Nanomachine for DNA Walking, Payload Release, and Biosensing” published January 19, 2016 in the journal ACS Nano.

Nanobot

Li explains that, unlike conventional diagnostic testing methods that require sophisticated equipment, highly trained personnel and at least a day to get results, the 3D nanomachine technique can be used in most clinics and labs, with results in as little as a half-hour.

“We wanted something to be simple,” he says. “The design is complicated, but the way you use it is extremely simple. All you need is to mix things together and wait to see the fluorescent signal.”

Graduate student Xiaolong Yang is the lead author of the team’s recent paper.

“If one day the 3D nanomachine technique is applied to real clinical service for primary-stage patients’ disease diagnostic, it will save thousands of lives,” he says.

“Also, this technique is full of potential for replacing the old-fashioned, time-consuming and labor intensive diagnostic technique in the future medical community. This is a very simple tool, but it could highly impact future medical care.”

The next step in the research, says Li, is to incorporate DNA strands that can capture specific micro ribonucleic acid, or microRNA, onto the nanomachine. MicroRNA “is a very important biomarker for cancer. We want to use the nanomachine to detect cancer by means of detecting circulating microRNA in human serum.”

The researchers are also exploring ways to commercialize their nanomachine so that the machine can be used easily for disease screening.

The group’s innovation has already been well received in the scientific community. A top journal in the field of analytic chemistry, Analyst, named Li’s research team one of the journal’s “Emerging Investigators,” with the team’s recent paper accepted as part of “Emerging Investigators” themed collection.

This article originally appeared in The Brock News.

Related Articles Read More >

Dexcom One
How Dexcom’s portfolio goes beyond highly-anticipated next-gen G7
A portrait of Stryker executive Siddarth Satish
How Stryker includes users for product design in the digital age
A Medtronic HVAD pump opened up to show the inner workings
Medtronic investigates HVAD pump welds after patient deaths
Galien Foundation 2022 nominees
18 of the world’s most innovative medical technologies

DeviceTalks Weekly.

May 20, 2022
DeviceTalks Boston Post-Game – Editors’ Top Moments, Insulet’s Eric Benjamin on future of Omnipod 5
See More >

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
DeviceTalks

DeviceTalks is a conversation among medical technology leaders. It's events, podcasts, webinars and one-on-one exchanges of ideas & insights.

DeviceTalks

New MedTech Resource

Medical Tubing

Enewsletter Subscriptions

Enewsletter Subscriptions

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech 100 Index
  • Medical Tubing + Extrusion
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to E-newsletter
  • Attend our Monthly Webinars
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2022 WTWH Media, LLC. All Rights Reserved. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech